Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | District Solan, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyOct 20, 2023 · 6 inspections, 2 with FDA action |
Recalls
- Aug 27, 2026 · Class III · Macleods Pharmaceuticals Limited
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Lots: Lot: BOB22321A, Exp 07-31-2027. - Nov 25, 2024 · Class II · Macleods Pharmaceuticals Ltd
Failed Impurities/Degradation Specifications
Lots: Lot# BOB12318A Exp 07/31/2027 - Feb 16, 2022 · Class II · Macleods Pharma Usa Inc
cGmp Deviations
Lots: Lot #: BOB42029A, BOB4202B, Exp. Date 09/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Olanzapine: every company that makes it
- Form
- tablet, film coated, oral
- Strength
- 15 mg
- Approval
- ANDA ANDA202862
- On the market since
- Aug 22, 2014
- Package NDCs
33342-071-0733342-071-1133342-071-1233342-071-1533342-071-44- Official label
- DailyMed (National Library of Medicine), updated Mar 5, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?